Navigation Links
'InvoiceCHECK' Cuts Prescription Benefit Waste
Date:12/5/2007

Unique Product from TRICAST Eliminates Annual Audits & Contentious Audit

Recovery Attempts; Provides Ongoing Compliance

MILWAUKEE, Dec. 5 /PRNewswire/ -- InvoiceCHECK, an innovative forensic prescription claims audit designed to verify PBM claims billings for each invoice, has been introduced by TRICAST.

InvoiceCHECK replaces annual retrospective audits by auditing claims each time a company receives an invoice for its prescription benefit claims.

"Every time that an employer receives a bill, we run the claims on the invoice through our system to make sure the invoice is correct and the client has been properly billed," said Greg Rucinski, TRICAST President. "If there are any discrepancies in your contract pricing or your plan design, we find them every two weeks instead of letting them pile up over a year and then doing a big, retrospective audit."

This exciting new product uses TRICAST analytics and proprietary software applications to deliver significant value to employers who sponsor pharmacy benefits, including:

-- a basis for sarbanes oxley compliance and fiduciary accountability

-- no more annual retrospective audits

-- no more potentially contentious audit recovery attempts

-- on-going compliance with contract pricing and plan design

-- up-to-date and immediate financial reporting

"Think of it as preventive maintenance, like changing your oil every 3,000 miles," said John Adler, TRICAST National Practice Leader. "It costs about $20 to change your oil. What happens if you don't? Your engine is ruined."

"InvoiceCHECK provides a 'sentinel effect' to assure you that billing discrepancies are caught and corrected before they grow into a lot of money," Adler said. "Conversely, waiting to do an annual, retrospective audit often leads to a cumbersome, time-consuming, contentious process that identifies errors but does not result in total recovery of the identified dollars. If a plan sponsor still needs an annual audit, InvoiceCHECK is cumulative, so it also fills this need."

"InvoiceCHECK provides verification that your PBM is paying claims according to your contract pricing and plan design," added Rucinski. "This product is designed as a basis for communication in lieu of litigation. It is much easier to fix problems when they are a few weeks old."

"When we engage a client for on-going management, we typically identify 5-7% of waste in annual pharmacy benefit dollars," said Adler. "We think that InvoiceCHECK is a natural starting point to find process improvement opportunities and eliminate cost in-efficiencies."

About TRICAST

TRICAST, founded in Milwaukee in 1997, uses Rx and medical claims analysis to find, fix, and forecast risk in a variety of environments for self-funded employers, health plans, insurance companies, and Taft Hartley Funds. The company also provides a platform for ROI decision support and the communication strategies necessary to successfully implement them. The net result is lower annual trend and improved risk management.

TRICAST delivers data-driven cost control solutions every day and offers programs, products, and applications for pharmacy benefits that assist in controlling overall healthcare costs.

For business inquiries only, please contact John Adler, National Practice Leaderat 414.302.9733 or visit http://www.tricast.com. Media inquiries should be directed to Michael Beightol, Coyote Marsh & Associates, Inc., 847.277.7353.


'/>"/>
SOURCE Tricast, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Updates Prescription Guidelines for Blood Thinner
2. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
3. Prescription labels geared toward pharmacies, not patients
4. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington
5. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
6. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
7. AUDIO from Medialink and Pfizer: A New Prescription for Safer Drugs
8. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
9. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
10. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
11. New Pharmacys Owners Go Beyond Your Prescription
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... The National Campaign to Prevent Teen ... to Contraception for Women Servicemembers and Dependents Act of 2017. The bill, introduced ... to ensure that all members of the Armed Forces receive high quality education ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of ... rating of “A” and its outlook as “stable.” At the same time, the ratings ... fallen in recent years, dip below “capital adequacy” thresholds required for its strong rating. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... or hERG liability could substantially improve drug safety and minimize the cost of ... for validating ion channel inhibition using cell lines and for cardiac toxicity using ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... for the North East region. Côté has 20+ years of experience within the ... Phytomer, Côté worked with an array of high-end cosmetic brands, retail brands and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017 The Global ... Forecast to 2022 report has covered and analysed the potential ... information on market size, shares and growth factors. The report ... challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major ...
(Date:4/19/2017)... April 19, 2017 ... immune response in pets such as canine, avian ... of various types such as Attenuated Live Vaccines, ... DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines ... or bacteria, which have been weakend under laboratory ...
Breaking Medicine Technology: